Cite
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
MLA
Wang, Jun, et al. “Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer Immunotherapy.” Nature Medicine, vol. 25, no. 4, Apr. 2019, p. 656. EBSCOhost, https://doi.org/10.1038/s41591-019-0374-x.
APA
Wang, J., Sun, J., Liu, L. N., Flies, D. B., Nie, X., Toki, M., & Zhang, J. (2019). Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy. Nature Medicine, 25(4), 656. https://doi.org/10.1038/s41591-019-0374-x
Chicago
Wang, Jun, Jingwei Sun, Linda N. Liu, Dallas B. Flies, Xinxin Nie, Maria Toki, and Jianping Zhang. 2019. “Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer Immunotherapy.” Nature Medicine 25 (4): 656. doi:10.1038/s41591-019-0374-x.